Post by
SpaceLabs on Nov 15, 2021 11:49am
Argus Report: Analysts TARGET C$16, read TODAY's NR, WOW !
Argus Research Initiates Equity Research Report Coverage on XORTX Therapeutics Inc. (Nasdaq: XRTX)
Comment by
Anklebiter42 on Nov 15, 2021 12:01pm
Wait a minute Spacelab..... I thought you were heading to the rat poision coins? Green day and your all of a sudden bullish. You flip-flop more than a politician. HAHA. Does the CEO still have to resign?
Comment by
SpaceLabs on Nov 15, 2021 1:48pm
ABcd, you sounding Gaga GooGoo today, I am not Bullish AT ALL as long as this Dr. CEO runs the show on Nasdaq/TSX. I want him to devote ALL his TIME to PRODUCT DEVELOPMENT and let a seasoned CEO take that job, no flip and NO FLOP dude. XRX under his leadership is a YOYO, I have 200K PP warrants at 35pence . 1 Analyst ARGUS FAILED to IGNITE today, maybe tomorrow, we shall SEE !!
Comment by
Richmond on Nov 15, 2021 1:53pm
I AGREE AB42. Xirtex Executives are Full of Shiitts!!!. This Shiittt can't go over $4, Let alone $16.00. THESE SKUNKS ARE CROOKS. Don't invest in XORTEX!!! LIARS!!!!. you'll be sorry like most of us, bagholders!!! Rollback to $9.00 and we've lost 80% of share value!!!